Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 127

    1.

    Impact of venous thromboembolism and anticoagulation on cancer and cancer survival.

    Kuderer NM, Ortel TL, Francis CW.

    J Clin Oncol. 2009 Oct 10;27(29):4902-11. Epub 2009 Sep 8. Review.PMID: 19738120 [PubMed - indexed for MEDLINE]Related articles

    2.

    Update of the guidelines for lupus anticoagulant detection.

    Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, De Groot PG.

    J Thromb Haemost. 2009 Oct;7(10):1737-40. Epub 2009 Jul 17.PMID: 19624461 [PubMed - in process]Related articles

    3.

    Recent developments in topical thrombins.

    Kessler CM, Ortel TL.

    Thromb Haemost. 2009 Jul;102(1):15-24. Review.PMID: 19572062 [PubMed - indexed for MEDLINE]Related articles

    4.

    Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI/NIH guidelines.

    Nichols WL, Rick ME, Ortel TL, Montgomery RR, Sadler JE, Yawn BP, James AH, Hultin MB, Manco-Johnson MJ, Weinstein M.

    Am J Hematol. 2009 Jun;84(6):366-70.PMID: 19415721 [PubMed - indexed for MEDLINE]Related articles

    5.

    Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008).

    Zakarija A, Kwaan HC, Moake JL, Bandarenko N, Pandey DK, McKoy JM, Yarnold PR, Raisch DW, Winters JL, Raife TJ, Cursio JF, Luu TH, Richey EA, Fisher MJ, Ortel TL, Tallman MS, Zheng XL, Matsumoto M, Fujimura Y, Bennett CL.

    Kidney Int Suppl. 2009 Feb;(112):S20-4. Review.PMID: 19180126 [PubMed - indexed for MEDLINE]Related articles

    6.

    Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology.

    Wagman LD, Baird MF, Bennett CL, Bockenstedt PL, Cataland SR, Fanikos J, Fogarty PF, Goldhaber SZ, Grover TS, Haire W, Hassoun H, Hutchinson S, Jahanzeb M, Lee J, Linenberger ML, Millenson MM, Ortel TL, Salem R, Smith JL, Streiff MB, Vedantham S; National Comprehensive Cancer Network.

    J Natl Compr Canc Netw. 2008 Sep;6(8):716-53. No abstract available. PMID: 18926086 [PubMed - indexed for MEDLINE]Related articles

    7.

    Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia.

    Whitlatch NL, Perry SL, Ortel TL.

    Thromb Haemost. 2008 Oct;100(4):678-84.PMID: 18841292 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Heparin-dependent platelet factor 4 antibodies and the impact of renal function on clinical outcomes: a retrospective study in hospitalized patients.

    Perry SL, Whitlatch NL, Ortel TL.

    J Thromb Thrombolysis. 2009 Aug;28(2):146-50. Epub 2008 Oct 7.PMID: 18839279 [PubMed - in process]Related articlesFree article

    9.

    von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).

    Nichols WL, Hultin MB, James AH, Manco-Johnson MJ, Montgomery RR, Ortel TL, Rick ME, Sadler JE, Weinstein M, Yawn BP.

    Haemophilia. 2008 Mar;14(2):171-232.PMID: 18315614 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prevention and treatment of deep venous thrombosis.

    Ortel TL.

    Vascular. 2008 Mar-Apr;16 Suppl 1:S64-70. Erratum in: Vascular. 2009 May-Jun;17(3):181. PMID: 18544309 [PubMed - in process]Related articles

    11.

    Thrombophilias: when should we test and how does it help?

    Whitlatch NL, Ortel TL.

    Semin Respir Crit Care Med. 2008 Feb;29(1):25-39. Review.PMID: 18302084 [PubMed - indexed for MEDLINE]Related articles

    12.

    Evolution of adverse changes in stored RBCs.

    Bennett-Guerrero E, Veldman TH, Doctor A, Telen MJ, Ortel TL, Reid TS, Mulherin MA, Zhu H, Buck RD, Califf RM, McMahon TJ.

    Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17063-8. Epub 2007 Oct 11.PMID: 17940021 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project.

    Bennett CL, Kim B, Zakarija A, Bandarenko N, Pandey DK, Buffie CG, McKoy JM, Tevar AD, Cursio JF, Yarnold PR, Kwaan HC, De Masi D, Sarode R, Raife TJ, Kiss JE, Raisch DW, Davidson C, Sadler JE, Ortel TL, Zheng XL, Kato S, Matsumoto M, Uemura M, Fujimura Y; SERF-TTP Research Group.

    J Am Coll Cardiol. 2007 Sep 18;50(12):1138-43. Epub 2007 Sep 4.PMID: 17868804 [PubMed - indexed for MEDLINE]Related articles

    14.

    Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients.

    Schroder JN, Daneshmand MA, Villamizar NR, Petersen RP, Blue LJ, Welsby IJ, Lodge AJ, Ortel TL, Rogers JG, Milano CA.

    Ann Thorac Surg. 2007 Sep;84(3):841-5; discussion 845-6.PMID: 17720387 [PubMed - indexed for MEDLINE]Related articles

    15.

    Direct-to-patient expert system and home INR monitoring improves control of oral anticoagulation.

    O'Shea SI, Arcasoy MO, Samsa G, Cummings SE, Thames EH, Surwit RS, Ortel TL.

    J Thromb Thrombolysis. 2008 Aug;26(1):14-21. Epub 2007 Jul 8.PMID: 17616845 [PubMed - indexed for MEDLINE]Related articles

    16.

    Invited commentary.

    Welsby IJ, Ortel TL.

    Ann Thorac Surg. 2007 Jul;84(1):168-9. No abstract available. PMID: 17588405 [PubMed - indexed for MEDLINE]Related articles

    17.

    Influence of sample collection and storage on the detection of platelet factor 4-heparin antibodies.

    Krakow EF, Goudar R, Petzold E, Suvarna S, Last M, Welsby IJ, Ortel TL, Arepally GM.

    Am J Clin Pathol. 2007 Jul;128(1):150-5.PMID: 17580283 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Age and dose sensitivities in the 2-butoxyethanol F344 rat model of hemolytic anemia and disseminated thrombosis.

    Ramot Y, Lewis DA, Ortel TL, Streicker M, Moser G, Elmore S, Ward SM, Peddada S, Nyska A.

    Exp Toxicol Pathol. 2007 Apr;58(5):311-22. Epub 2007 Jan 29.PMID: 17261363 [PubMed - indexed for MEDLINE]Related articles

    19.

    A multi-dose pharmacokinetic study of dalteparin in haemodialysis patients.

    Perry SL, O'Shea SI, Byrne S, Szczech LA, Ortel TL.

    Thromb Haemost. 2006 Dec;96(6):750-5.PMID: 17139369 [PubMed - indexed for MEDLINE]Related articles

    20.

    The U.S. Thrombosis and Hemostasis Centers pilot sites program.

    Dowling NF, Beckman MG, Manco-Johnson M, Hassell K, Philipp CS, Michaels LA, Moll S, Heit JA, Penner J, Kulkarni R, Pipe S, Bockenstedt P, Andersen J, Crudder S, James AH, Zimmerman S, Ortel TL.

    J Thromb Thrombolysis. 2007 Feb;23(1):1-7.PMID: 17111206 [PubMed - indexed for MEDLINE]Related articles

    21.

    Venous thromboembolic disease. Clinical practice guidelines in oncology.

    Wagman LD, Baird MF, Bennett CL, Bockenstedt PL, Cataland SR, Fanikos J, Fogarty PF, Goldhaber SZ, Grover TS, Haire W, Hassoun H, Jahanzeb M, Leung LL, Linenberger ML, Millenson MM, Ortel TL, Salem R, Smith JL, Streiff MB; National Comprehensive Cancer Network.

    J Natl Compr Canc Netw. 2006 Oct;4(9):838-69. No abstract available. PMID: 17020664 [PubMed - indexed for MEDLINE]Related articles

    22.

    Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves.

    James AH, Brancazio LR, Gehrig TR, Wang A, Ortel TL.

    J Matern Fetal Neonatal Med. 2006 Sep;19(9):543-9. Review.PMID: 16966122 [PubMed - indexed for MEDLINE]Related articles

    23.

    Clinical practice. Heparin-induced thrombocytopenia.

    Arepally GM, Ortel TL.

    N Engl J Med. 2006 Aug 24;355(8):809-17. Review. No abstract available. PMID: 16928996 [PubMed - indexed for MEDLINE]Related articles

    24.

    The kaolin-activated Thrombelastograph predicts bleeding after cardiac surgery.

    Welsby IJ, Jiao K, Ortel TL, Brudney CS, Roche AM, Bennett-Guerrero E, Gan TJ.

    J Cardiothorac Vasc Anesth. 2006 Aug;20(4):531-5. Epub 2006 Jan 6.PMID: 16884984 [PubMed - indexed for MEDLINE]Related articles

    25.

    The antiphospholipid syndrome: what are we really measuring? How do we measure it? And how do we treat it?

    Ortel TL.

    J Thromb Thrombolysis. 2006 Feb;21(1):79-83. Review.PMID: 16475047 [PubMed - indexed for MEDLINE]Related articles

    26.

    Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function.

    Hayward CP, Harrison P, Cattaneo M, Ortel TL, Rao AK; Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.

    J Thromb Haemost. 2006 Feb;4(2):312-9. Review.PMID: 16420557 [PubMed - indexed for MEDLINE]Related articles

    27.

    Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies.

    Perry SL, Samsa GP, Ortel TL.

    Thromb Haemost. 2005 Dec;94(6):1196-202.PMID: 16411394 [PubMed - indexed for MEDLINE]Related articles

    28.

    The reactivity of paired plasma and serum samples are comparable in the anticardiolipin and anti-beta2-glycoprotein-1 ELISAs.

    Lewis DA, Pound ML, Ortel TL.

    J Thromb Haemost. 2006 Jan;4(1):265-7. No abstract available. PMID: 16409482 [PubMed - indexed for MEDLINE]Related articles

    29.

    Hemostatic activation in a chemically induced rat model of severe hemolysis and thrombosis.

    Lewis DA, Nyska A, Potti A, Hoke HA, Klemp KF, Ward SM, Peddada SD, Wu J, Ortel TL.

    Thromb Res. 2006;118(6):747-53. Epub 2006 Jan 6.PMID: 16405975 [PubMed - indexed for MEDLINE]Related articles

    30.

    Thrombophilia and thrombosis in thrombotic thrombocytopenic purpura.

    Potti A, Ramiah V, Ortel TL.

    Semin Thromb Hemost. 2005 Dec;31(6):652-8. Review.PMID: 16388416 [PubMed - indexed for MEDLINE]Related articles

    31.

    Continuing anticoagulation following venous thromboembolism.

    Krakow E, Ortel TL.

    JAMA. 2005 Dec 28;294(24):3088; author reply 3088-9. No abstract available. PMID: 16380585 [PubMed - indexed for MEDLINE]Related articles

    32.

    Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery.

    Bennett-Guerrero E, Slaughter TF, White WD, Welsby IJ, Greenberg CS, El-Moalem H, Ortel TL.

    J Thorac Cardiovasc Surg. 2005 Dec;130(6):1567-72.PMID: 16308000 [PubMed - indexed for MEDLINE]Related articles

    33.

    Thrombosis and the antiphospholipid syndrome.

    Ortel TL.

    Hematology Am Soc Hematol Educ Program. 2005:462-8.PMID: 16304421 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Gene-expression patterns predict phenotypes of immune-mediated thrombosis.

    Potti A, Bild A, Dressman HK, Lewis DA, Nevins JR, Ortel TL.

    Blood. 2006 Feb 15;107(4):1391-6. Epub 2005 Nov 1.PMID: 16263789 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Heparin-induced thrombocytopenia: clinical presentations and therapeutic management.

    Larned ZL, O'Shea SI, Ortel TL.

    Clin Adv Hematol Oncol. 2003 Jun;1(6):356-64. Review.PMID: 16224435 [PubMed - indexed for MEDLINE]Related articles

    36.

    Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy.

    James AH, Brancazio LR, Ortel TL.

    Clin Adv Hematol Oncol. 2005 Mar;3(3):187-97. Review.PMID: 16166990 [PubMed - indexed for MEDLINE]Related articles

    37.

    Dialogue with patient care organizations.

    Costello R, Young J, Burkholder R, Cranston J, Ortel TL, Dentali S, Cotter R, O'sullivan Maillet J, Hawkins B, Craig Hooper W.

    Thromb Res. 2005;117(1-2):211-22; discussion 223-5. Epub 2005 Aug 25. No abstract available. PMID: 16125754 [PubMed - indexed for MEDLINE]Related articles

    38.

    Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failure.

    Welty-Wolf KE, Carraway MS, Ortel TL, Ghio AJ, Idell S, Egan J, Zhu X, Jiao JA, Wong HC, Piantadosi CA.

    Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L21-31. Epub 2005 Aug 12.PMID: 16100288 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Clinical implications for patients on antithrombotic therapy while taking supplements.

    Ortel TL.

    Thromb Res. 2005;117(1-2):75-80; discussion 113-5. Epub 2005 Jun 14. No abstract available. PMID: 15961141 [PubMed - indexed for MEDLINE]Related articles

    40.

    Phospholipid vesicles interfere with the binding of antibody fragments to the light chain of factor VIII.

    Lewis DA, Bovenschen N, Mertens K, Voorberg J, Ortel TL.

    Thromb Haemost. 2005 May;93(5):833-41.PMID: 15886796 [PubMed - indexed for MEDLINE]Related articles

    41.

    von Willebrand's disease diagnosed after menorrhagia worsened from levonorgestrel intrauterine system.

    Lukes AS, Perry S, Ortel TL.

    Obstet Gynecol. 2005 May;105(5 Pt 2):1223-6.PMID: 15863590 [PubMed - indexed for MEDLINE]Related articles

    42.

    Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

    Haynes BF, Fleming J, St Clair EW, Katinger H, Stiegler G, Kunert R, Robinson J, Scearce RM, Plonk K, Staats HF, Ortel TL, Liao HX, Alam SM.

    Science. 2005 Jun 24;308(5730):1906-8. Epub 2005 Apr 28.PMID: 15860590 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Antihuman factor V antibodies after use of relatively pure bovine thrombin.

    Lawson JH, Lynn KA, Vanmatre RM, Domzalski T, Klemp KF, Ortel TL, Niklason LE, Parker W.

    Ann Thorac Surg. 2005 Mar;79(3):1037-8.PMID: 15734434 [PubMed - indexed for MEDLINE]Related articles

    44.

    Warfarin in antiphospholipid syndrome--time to explore new horizons.

    Erkan D, Ortel TL, Lockshin MD.

    J Rheumatol. 2005 Feb;32(2):208-12. No abstract available. PMID: 15693072 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Regulatable aptamers in medicine: focus on antithrombotic strategies.

    Potti A, Rusconi CP, Sullenger BA, Ortel TL.

    Expert Opin Biol Ther. 2004 Oct;4(10):1641-7. Review.PMID: 15461575 [PubMed - indexed for MEDLINE]Related articles

    46.

    Use of a new platelet function analyzer to detect von Willebrand disease in women with menorrhagia.

    James AH, Lukes AS, Brancazio LR, Thames E, Ortel TL.

    Am J Obstet Gynecol. 2004 Aug;191(2):449-55.PMID: 15343220 [PubMed - indexed for MEDLINE]Related articles

    47.

    Coagulation abnormalities in patients with hip osteonecrosis.

    Korompilias AV, Ortel TL, Urbaniak JR.

    Orthop Clin North Am. 2004 Jul;35(3):265-71, vii.PMID: 15271534 [PubMed - indexed for MEDLINE]Related articles

    48.

    Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome.

    Rand JH, Wu XX, Lapinski R, van Heerde WL, Reutelingsperger CP, Chen PP, Ortel TL.

    Blood. 2004 Nov 1;104(9):2783-90. Epub 2004 Jul 8.PMID: 15242878 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    A review of the therapeutic uses of thrombin.

    Lundblad RL, Bradshaw RA, Gabriel D, Ortel TL, Lawson J, Mann KG.

    Thromb Haemost. 2004 May;91(5):851-60. Review.PMID: 15116244 [PubMed - indexed for MEDLINE]Related articles

    50.

    Management of lepirudin therapy for a patient with antiphospholipid antibody syndrome using the whole blood ecarin clot time and activated partial thromboplastin time.

    Perry SL, O'Shea SI, Ortel TL.

    Blood Coagul Fibrinolysis. 2003 Sep;14(6):601-4.PMID: 12960616 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...